Related Experiment Video
Updated: Jun 29, 2025

Capture and Identification of RNA-binding Proteins by Using Click Chemistry-assisted RNA-interactome Capture CARIC Strategy
Published on: October 19, 2018
RNA binding proteins in cardiovascular development and disease.
Sunil K Verma1, Muge N Kuyumcu-Martinez2
1Department of Molecular Physiology and Biological Physics, University of Virginia School of Medicine Charlottesville, VA, United States.
Mutations in RNA binding proteins (RBPs) contribute to congenital heart disease (CHD), the most common birth defect. Understanding RBPs in heart development may lead to novel RNA-based treatments for CHD.
Area of Science:
- Cardiovascular Biology
- Molecular Genetics
- Developmental Biology
Background:
- Congenital heart disease (CHD) is a prevalent birth defect with significant mortality and lifelong complications.
- Mutations or variants in RNA binding proteins (RBPs) are increasingly recognized as contributing factors to CHD.
- The specific roles of RBPs in embryonic heart development and their direct links to CHD remain largely unexplored.
Purpose of the Study:
- To review current knowledge on specific RBPs implicated in congenital heart disease.
- To highlight the significance of RBPs as regulators of gene expression in cardiac development.
- To underscore the potential of RNA-based therapies for treating CHD.
Main Methods:
- Literature review of studies investigating RBPs in congenital heart disease.
- Analysis of the known functions of RBPs in gene regulation, particularly mRNA processing and protein production.
- Exploration of emerging RNA-based methodologies and therapies applicable to CHD research.
Main Results:
- RBPs are crucial regulators of the mRNA and protein landscape, influencing cellular function.
- Specific RBPs have been identified as potential contributors to the pathogenesis of CHD.
- The developing heart's reliance on precise gene regulation makes it vulnerable to RBP dysfunction.
Conclusions:
- Further investigation into RBPs' roles in heart development is essential for understanding CHD.
- Identifying RBP target RNAs in the embryonic heart can elucidate disease mechanisms.
- This research paves the way for developing innovative RNA-based therapeutic strategies for congenital heart disease.
Related Concept Videos
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
RNA Splicing
Regulation of Angiogenesis and Blood Supply
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Regulation of Expression at Multiple Steps
RNA Stability

